Melatonin in Relapsing-Remitting Multiple Sclerosis Patients

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2011
The purpose of this study is to determine whether melatonin is effective in the treatment of relapsing-remitting multiple sclerosis patients as a supplement to the main disease-modifying drugs.
Epistemonikos ID: 3781dfdface030769f7adfa167f3db72ff407825
First added on: Mar 31, 2022